Medical Oncologist
CION Cancer Clinics
A VUS in BRCA1: what an uncertain result really means | CION Cancer Clinics
A variant of uncertain significance in BRCA1 means the laboratory found a change in the gene but cannot yet say whether it raises cancer risk. It is not a positive result. Your care should be planned on your family history, not on the variant. This page explains why these results are common in Indian families, what they change and how they are settled over time. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does a VUS in BRCA1 actually mean?
- What a BRCA1 VUS changes, and what it leaves alone
- How a BRCA1 VUS gets settled over time
- The words you will meet, in plain language
- A harmful BRCA1 result compared with a VUS
- Four things families assume about a BRCA1 VUS
- What this page cannot tell you
- Common questions about a BRCA1 VUS
The short answer
What does a VUS in BRCA1 actually mean?
It means the laboratory found a spelling change in your BRCA1 gene and cannot yet say whether it matters. A variant of uncertain significance, or VUS, is not a positive result. Your treatment, your screening and any talk of preventive surgery should be planned as if no BRCA1 fault had been found, using your family history instead.
Why BRCA1 results come back uncertain
BRCA1 is a long gene, and there are thousands of possible single-letter changes in it. Many have been seen in only a handful of families worldwide. Until enough people carrying the same change have been studied, the laboratory cannot tell whether it breaks the gene or is a harmless difference, like a spelling variation that does not change the meaning of a word.
Why Indian families see more of them
The large databases laboratories rely on were built mostly from families of European ancestry. A change that is common and harmless in Telangana may never have been recorded there. So Indian patients receive uncertain results more often. That reflects a gap in the data, not something worrying about your family.
Most uncertain variants that are later reclassified turn out to be harmless.In practice
What a BRCA1 VUS changes, and what it leaves alone
Almost everything is decided as if the VUS were not there. These are the four decisions families ask about most.
Your cancer treatment
A VUS should not decide surgery type or the use of medicines chosen because of a BRCA fault. Your oncologist plans treatment on the tumour itself and on any clearly harmful findings.
Preventive surgery
Removing healthy breasts or ovaries because of a VUS is not advised. If your family history alone is strong enough, that conversation can still happen, but on that basis.
A decision this big should rest on evidence, not on a question mark.Your screening
Checks are set by your personal and family history. A strong family pattern can still earn early or extra screening, with or without the VUS.
What sets the plan
- Who in the family had cancer
- How young they were
- Which cancers, and on which side
Your relatives
Relatives are not normally tested for a VUS, because a result either way would tell them nothing. Occasionally a lab asks affected relatives to test, to help settle the variant.
Not sure whether this applies to you?
Ask an oncologistWhat happens next
How a BRCA1 VUS gets settled over time
-
The laboratory reports what it found
Your report names the exact change and labels it uncertain. It should say what evidence was weighed and what was missing.
-
The change is shared with other laboratories
Many labs submit their findings to shared public databases such as ClinVar. Each new family carrying the same change adds evidence.
-
Evidence builds from several directions
Laboratory studies test whether the change stops the gene working. BRCA1 is one of the genes where these studies are most advanced. Features of tumours in carriers, and whether the change travels with cancer through a family, also count.
-
The label is reviewed
When the evidence is strong enough, the variant is moved to benign or to pathogenic. This can take a short while or many years, and some changes stay uncertain.
-
You are told, if you can be found
Labs and clinics differ in how they recontact patients. Keep your report, keep your phone number current with the clinic, and ask at each review whether anything has changed.
On your report
The words you will meet, in plain language
- VUS
- Variant of uncertain significance. A change found in the gene whose effect on cancer risk is not yet known.
- Missense variant
- A change that swaps one building block of the protein for another. Most uncertain BRCA1 results are of this type.
- Reclassification
- A change in a variant's label as evidence grows. Most move towards benign, and a smaller number towards pathogenic.
- ClinVar
- A free public database where laboratories share how they have classified each variant. Labs sometimes disagree.
- Functional study
- A laboratory experiment that checks whether a specific change stops the BRCA1 protein from repairing DNA.
- Segregation study
- Testing relatives with and without cancer to see whether the variant travels with the illness through the family.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
A harmful BRCA1 result compared with a VUS
Pathogenic BRCA1
BRCA1 VUS
Relatives can be tested for that exact fault
Relatives are not usually tested for the VUS
Screening follows a BRCA1 carrier plan
Screening follows your family history
Preventive surgery can be discussed
Preventive surgery should not rest on it
Certain targeted medicines may be considered
Treatment choices are made without it
Commonly believed
Four things families assume about a BRCA1 VUS
"Uncertain means half positive, so I should act as if I carry it."
A VUS is not a halfway result. Acting on it can lead to surgery or worry you did not need. Your plan should follow your family history until the variant is settled.
"My sister should be tested for the same variant."
Testing a healthy relative for a VUS gives an answer nobody can use. If she is worried, she should be assessed on her own and the family's history.
"A different lab would give me a clear answer."
Sometimes labs do disagree, and a second opinion on classification can be reasonable. But no lab can create evidence that does not yet exist. Retesting the same gene rarely helps.
"If it is reclassified, someone will ring me."
Some labs recontact patients and some do not. The safest habit is to ask whenever you see your doctor, and to keep the clinic's record of your number up to date.
Being straight with you
What this page cannot tell you
It cannot tell you what your particular variant means. Two BRCA1 changes that look alike on paper can sit in very different places in the gene, and some already have partial evidence leaning one way. What your specific variant means is a question for the counsellor who ordered the test.
It cannot predict when the answer will come
Some variants are settled quickly once a few more families are recorded. Others stay uncertain for a long time, especially changes seen mainly in Indian families. Studies of Indian BRCA1 variants are growing but are still small.
Who this does not apply to
If your report says pathogenic or likely pathogenic, you have a different result and a different plan. If your VUS is in another gene, the general idea is the same but the details are not. And if the tumour rather than your blood was tested, that is a separate question for your treating oncologist.
Bring the actual report to your appointment, not a photo of one page. The small print matters.Questions we are asked
Common questions about a BRCA1 VUS
Is a BRCA1 VUS a positive result?
No. It means a change was found whose effect is not yet known. It is not treated as positive and it is not treated as negative either. Your care is planned on your family history, as if the test had found no harmful change in BRCA1.
Should I have preventive surgery because of a VUS?
Not because of the VUS. Guidelines advise against removing healthy organs on the strength of an uncertain result. If your family history on its own is very strong, you can still discuss preventive options, but that decision should rest on the history.
How often do BRCA1 variants get reclassified?
Regularly, as more families are tested and more laboratory studies are published. Most reclassified uncertain variants are moved to benign. A smaller share are moved to pathogenic. Some stay uncertain for a long time.
Will my VUS affect PARP inhibitor treatment?
A germline VUS is not normally a reason to give these medicines. Your oncologist may test the tumour separately, which answers a different question about the cancer itself. That kind of testing is covered on our targeted therapy pages.
Should my children be tested for my VUS?
No. A result either way would not tell them anything useful about their risk. Their screening should follow the family history. If your variant is later reclassified as harmful, they can be offered a proper test then.
Can I ask the lab to look at my variant again?
Yes. You or your doctor can ask the lab whether the classification has been reviewed. Some labs review on request, and some do it on a routine cycle. Ask how they would inform you if the label changed.
Do I have to mention a VUS for marriage or insurance?
These are personal decisions. A VUS is not a diagnosis and is not evidence of a raised risk. India has no dedicated law on genetic discrimination, so it is worth discussing disclosure with your counsellor before sharing the report widely.
Who should explain my BRCA1 report to me?
A genetic counsellor or a clinical geneticist, ideally the team that ordered the test. They can read the evidence section of the report, check public databases, and set your screening plan from your family history. Explanations can be given in Telugu.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — BRCA Gene Changes: Cancer Risk and Genetic Testing
- ACMG (Genetics in Medicine) — Standards and guidelines for the interpretation of sequence variants
- ClinVar (NCBI) — ClinVar: public archive of variant interpretations
- MedlinePlus Genetics — BRCA1 gene
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Talk to us
Holding a BRCA1 report that says uncertain?
Bring the full report and a list of relatives who had cancer. A genetic counsellor will explain what it does and does not change for you and your family. One helpline serves every CION centre.